Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Abgenix and Genentech form new antibody collaboration

Jan. 29, 1999

Deltagen and Pfizer establish target validation agreement

Jan. 29, 1999

Three patents covering drug formulation technology issued to Delsys

Jan. 28, 1999

Deltagen enters another gene target validation collaboration

Jan. 28, 1999

Deltagen to validate target genes for Roche Bioscience

Jan. 26, 1999

Results of animal studies indicate ability of GeneSwitch to regulate gene therapy

Jan. 22, 1999

MorphoSys enters licensing agreement with Chiron for HuCAL

Jan. 22, 1999

Pharmacopeia enters research collaboration with Pharmacia & Upjohn

Jan. 21, 1999

AxyS and RPR enter second collaborative agreement

Jan. 21, 1999

PDL issues further licenses under its antibody humanization patents

Jan. 20, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...